MedTrace Logo

Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

NCT04595474 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 533

Last updated 2025-09-05

No results posted yet for this study

Summary

The aim of this study is to assess the prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes receiving care at Joslin clinic using noninvasive imaging and serum-based methods with the goal of identifying high-risk patients with advanced fibrosis who should be prioritized for specialty referral

Conditions

Interventions

DEVICE

Transient Elastography

Transient elastography is a noninvasive imaging modality used to assess NAFLD and advanced fibrosis

Sponsors & Collaborators

  • Joslin Diabetes Center

    lead OTHER

Principal Investigators

  • Osama Hamdy, MD PhD · Joslin Diabetes Center

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-14
Primary Completion
2022-08-19
Completion
2025-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04595474 on ClinicalTrials.gov